IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $26M
- YoY, 2025
- +63.1%
- 5-year CAGR
- +110.5%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $26M | +63.1% |
| 2024 | $16M | +153.1% |
| 2023 | $6.2M | +16.7% |
| 2022 | $5.3M | +54.6% |
| 2021 | $3.4M | +455.2% |
| 2020 | $621K | +4,335.7% |
| 2019 | $14K | — |